Ann: Encouraging Initial Data from CYP-006TK DFU Trial, page-40

I fail to see how an adverse event could occur. The application is basic wound care with a stem cell based medication being applied.

stem cells are naturally occuring in the body and we experience a gradual decline in volume as we age.

stem cells have been used for years in various applications almost exclusively by the elites of the worlds - some athletes have even opted for stem cell infusions over surgey with fantastic results ie no scaring or mobilty issues that surgery would ultimatly cause.

we are getting to the exciting end of science, CYP it seems has cracked the code and this will offer tremendous benefit to many people world wide. Very valuable IP

Congratulations to all holders.

Best of all this is just one product of many in the pipeline.